Navigating Health: Key Insights from WHO’s 2023 Essential Diagnostics List
In the realm of global health, the significance of timely and accurate diagnostics in identifying and managing diseases cannot be overstated. Recognizing this vital component, the World Health Organization (WHO) has been curating the Essential Diagnostics List (EDL) since 2018. This list acts as a beacon, guiding healthcare systems worldwide on the critical diagnostic tools necessary for effective patient care. It emerges from the collaborative efforts of experts, researchers, and healthcare professionals globally. As the healthcare landscape evolves, the EDL propels nations toward a future where accessible and precise diagnostics are cornerstones of well-functioning healthcare systems.
Praesens Care continues to leverage this crucial framework to align and expand our BIONEAR service offering, bridging the last mile and enhancing diagnostic access, always tailored to the local health landscape
Read the article
Use of BIONEAR to support routine and surveillance diagnostic services in Mombasa county
During a 4-month pilot study conducted by Praesens Care and JKUAT in collaboration with the Ministry of Health and the Department of Health of Mombasa and funded by FIND, a novel mobile medical laboratory, BIONEAR, was introduced to augment the existing health infrastructure in Mombasa County, Kenya. This pioneering initiative aimed to assess the efficacy and feasibility of integrating a mobile diagnostic laboratory into the local healthcare system.
The study successfully demonstrated the compelling value proposition of deploying such a mobile diagnostic laboratory. BIONEAR markedly enhanced access to essential medical diagnostic services for underserved populations, thus addressing a critical gap in healthcare delivery.
Moreover, it substantially improved service delivery efficiency to the residents of Mombasa County by notably reducing the turnaround time for testing. This expedited clinical management processes for patients, leading to more timely interventions and improved health outcomes.
Furthermore, the introduction of BIONEAR contributed to a notable reduction in travel distance and time for clients, particularly those residing near health facilities that previously did not offer such diagnostic services. This not only enhanced convenience for patients but also potentially increased the likelihood of timely diagnosis and treatment initiation.
Overall, the findings from this pilot study underscore the significant potential of mobile diagnostic laboratories in augmenting healthcare delivery, particularly in resource-limited settings like Mombasa County.
Read the article
Improving access to high quality diagnostic services via Private-Public-Partnerships
Recently (2023), the World Bank and IFC (International Finance Corporation) launched a report on how PPPs (Private-Public-Partnerships) can help improve access to affordable diagnostic services in emerging markets.
In the report they share feedback from interviews with stakeholders of PPPS around the globe and lessons learned from case studies.
Read the article
Belgian Defence's recently acquired BIONEAR partaking in the Military Parade on Belgian National Day
On the occasion of the Belgian National Day on the 21st of July, Praesens Care is proud to witness the BIONEAR took part in the Military Parade in Brussels.
Read the article
PRAESENS CARE, THE BELGIAN DEFENSE AND LHUB-ULB PROVIDE A FIRST: BIONEAR®, FIRST ISO15189 ACCREDITED MEDICAL MOBILE LAB
The Belgian Defence, the University Laboratory of Brussels (LHUB-ULB) and Praesens Care have been the very first to obtain the ISO15189 accreditation for a medical mobile lab. BELAC, the Belgian Accreditation body has audited for the first time the internationally recognized norms for fixed labs applied to a mobile lab.
Read the article
Praesens Care is finalist in the NATO INNOVATION CHALLENGE 2022
We are thrilled to announce that our RDOIT (Rapidly Deployable Outbreak Investigation Team) solution, BIONEAR®, is a finalist in the global 2022 NATO Innovation Challenge!
Read the article
47% of the global population has little to no access to diagnostics
In October 2021, The Lancet Commission on Diagnostics launched a publication to put the spotlight on the current status of the diagnostic landscape.
Read the article
